Biologic drugs are finding growing success in addressing chronic diseases — from diabetes and rheumatoid arthritis to multiple sclerosis and Crohn’s. A significant rise in self-injection therapies is contributing to… Read More »
Read More
We speak with Adam Shain, Director Business Development, Digital Healthcare, and Josh Hopkins, Program Manager, AdhereIT about the AdhereIT 360 Base and AdhereIT Clip – a runner up for The… Read More »
Read More
The Internet of Things (IoT) – defined simply as a system of internet-connected devices that collect and transfer data over a wireless network – has transformed healthcare, from electronic health… Read More »
Read More
HF+ gaining momentum with additional offerings, successful support for new drug launches and expert hiring ORLANDO, Fla. (June 8, 2021) – In direct response to the rapid growth of the… Read More »
Read More
Joint Webinar from Noble & Aptar Pharma Discusses How to Improve Patient Adherence and Compliance With Innovative Digital Healthcare Solutions Hear from Adam Shain, Business Development Director, Digital Healthcare, Aptar… Read More »
Read More
Startling statistics have revealed the magnitude of the global opioid epidemic. According to the World Health Organization (WHO), in 2018 about 58 million people worldwide used opioids, and another 35.6… Read More »
Read More
Part 1 of Noble’s Human Factors + Webinar Series: Regulatory Overview Join Noble’s Joe Reynolds and Joe Masci, along with Human Factors expert Kevin Cluff, in the first of our… Read More »
Read More
According to the US FDA, human factors engineering is an essential component of product development for drug delivery and medical devices. The US FDA recommends making it a robust part… Read More »
Read More
“Human Factors Plus” (HF+) is a natural extension of Noble’s deep understanding of the patient experience when it comes to self-administering drug therapies ORLANDO, Fla. (February 2, 2021) – Noble,… Read More »
Read More